AllerQuest, LLC is a leading company based in West Hartford, CT, specializing in the development and distribution of skin test reagents for the accurate diagnosis of penicillin allergy. With a team of experienced scientists, physicians, and pharmaceutical manufacturing experts, AllerQuest is dedicated to providing high-quality test reagents to assist healthcare providers in identifying patients at risk of potentially life-threatening reactions to penicillin antibiotics.
As of January 2, 2024, AllerQuest's flagship product, PRE-PEN, has been acquired by ALK-Abell, a renowned allergy pharmaceutical company. Under ALK-Abell's stewardship, allergists and healthcare providers can continue to rely on PRE-PEN as the only FDA-approved diagnostic skin test for evaluating penicillin allergy. With a mission to ensure patient safety and accurate diagnosis, AllerQuest remains committed to supporting healthcare professionals in the field of penicillin drug allergy testing.
Generated from the website